http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101844845-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-44 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101844845-B1 |
titleOfInvention | Composition for predicting susceptibility to drugs for the therapy of biliary tract cancer |
abstract | The present invention provides a composition comprising an agent for measuring the expression level of a gene, a protein and / or a microRNA capable of predicting susceptibility to a drug for treating a bile duct cancer, and a kit comprising the composition. The present invention also provides a method for predicting the sensitivity of a drug for treating biliary cancer by measuring the expression level of genes, proteins and / or microRNAs. |
priorityDate | 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 506.